Abstract:
A mattress for supporting a head and body of a patient is disclosed. The mattress includes an integrated deformable head support that can be molded into a desired shape to support the head of the infant. The deformable head support retains the desired shape after molding. The head support is received upon and extends above a top surface of a base layer of the mattress. The base layer and head support are formed from different materials where the material used to form the head support can be deformed and retains the desired shape. The head support has a U-shape or semi-ring shape to surround the top and sides of the head of an infant patient when the infant patient is positioned on the mattress. A cover layer is positioned over both the base layer and the head support.
Abstract:
A fetal monitoring device includes a piezofilm sheet, a first electrode, and a second electrode. A controller is operably connected to the piezofilm sheet, first electrode, and second electrode and receives a biopotential and a piezofilm signal. The controller derives at least one of a maternal heart rate and a uterine activity for the biopotential and derives at least one of a fetal heart rate and fetal motion detection from the piezofilm signal. The controller derives an index of fetal health and operate an indicator to present the derived index of fetal health.
Abstract:
A method and device for monitoring a fetal heart rate includes a reference fetal heart rate detected across an ultrasound depth zone of sensitivity. The ultrasound depth zone of sensitivity is scanned in overlapping increments of a first depth. An average fetal heart rate detected for each overlapping increment is tested for a coincidence with the reference fetal heart rate. Overlapping increments with the coincidence and a maximized signal quality rate are identified. An ultrasound depth increment of a second depth is selected representing the selected adjacent increments. Fetal heart rate is determined from an ultrasound signal returned from a scan depth of the second depth.
Abstract:
A method and device for monitoring a fetal heart rate includes a reference fetal heart rate detected across an ultrasound depth zone of sensitivity. The ultrasound depth zone of sensitivity is scanned in overlapping increments of a first depth. An average fetal heart rate detected for each overlapping increment is tested for a coincidence with the reference fetal heart rate. Overlapping increments with the coincidence and a maximized signal quality rate are identified. An ultrasound depth increment of a second depth is selected representing the selected adjacent increments. Fetal heart rate is determined from an ultrasound signal returned from a scan depth of the second depth.
Abstract:
The disclosed sensor assembly may be used in a patient monitoring system to monitor one or more physiological parameters of a patient. The sensor assembly may include a substrate and one or more electrodes, which may include a lattice structure to limit a contact area between the one or more electrodes and skin of the patient. The sensor assembly may include connectors or connector assemblies that facilitate connection between the one or more electrodes and a data acquisition unit. The sensor assembly may be especially useful for patients with sensitive skin, such as infants in a neonatal intensive care unit (NICU).
Abstract:
A fetal monitoring device includes a piezofilm sheet, a first electrode, and a second electrode. A controller is operably connected to the piezofilm sheet, first electrode, and second electrode and receives a biopotential and a piezofilm signal. The controller derives at least one of a maternal heart rate and a uterine activity for the biopotential and derives at least one of a fetal heart rate and fetal motion detection from the piezofilm signal. The controller derives an index of fetal health and operate an indicator to present the derived index of fetal health.